Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 11.68% and Operating profit at -24.53% over the last 5 years
2
The company has declared Negative results for the last 6 consecutive quarters
3
With ROE of 3.52%, it has a expensive valuation with a 3.21 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.37%
0%
-14.37%
6 Months
-4.42%
0%
-4.42%
1 Year
-7.07%
0%
-7.07%
2 Years
-31.75%
0%
-31.75%
3 Years
-61.38%
0%
-61.38%
4 Years
-78.09%
0%
-78.09%
5 Years
-82.52%
0%
-82.52%
Yunnan Botanee Bio-Technology Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.68%
EBIT Growth (5y)
-24.53%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.87
Tax Ratio
23.11%
Dividend Payout Ratio
50.25%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
72.61%
ROE (avg)
13.84%
Valuation key factors
Factor
Value
P/E Ratio
91
Industry P/E
Price to Book Value
3.21
EV to EBIT
99.97
EV to EBITDA
39.87
EV to Capital Employed
5.41
EV to Sales
3.14
PEG Ratio
NA
Dividend Yield
1.31%
ROCE (Latest)
5.41%
ROE (Latest)
3.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
1,118.00
948.80
17.83%
Operating Profit (PBDIT) excl Other Income
81.20
97.00
-16.29%
Interest
4.90
3.90
25.64%
Exceptional Items
-6.80
4.10
-265.85%
Consolidate Net Profit
62.10
31.20
99.04%
Operating Profit Margin (Excl OI)
72.60%
35.40%
3.72%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 17.83% vs -12.82% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 99.04% vs -81.90% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,288.30
5,672.20
-6.77%
Operating Profit (PBDIT) excl Other Income
742.90
652.90
13.78%
Interest
19.80
18.70
5.88%
Exceptional Items
8.00
61.90
-87.08%
Consolidate Net Profit
516.80
494.80
4.45%
Operating Profit Margin (Excl OI)
89.90%
73.90%
1.60%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.77% vs 3.84% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 4.45% vs -34.83% in Dec 2024
About Yunnan Botanee Bio-Technology Group Co., Ltd. 
Yunnan Botanee Bio-Technology Group Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






